Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Bisphosphonate Therapy in Langerhans Cell Histiocytosis: An International Retrospective Descriptive Study

Deepak Chellapandian, MD MBBS, Polyzois Makras, MD PhD, Gregory Kaltsas, MD PhD, Cor van den Bos, MDPhD, Anne-Sophie Carret, MD, Sheila Weitzman, MB BCh, FRCP, Maarten Egeler, MD PhD, Oussama Abla, MD

Blood (2015) 126 (23): 2209.

https://doi.org/10.1182/blood.V126.23.2209.2209

Published: 2015

Journal Articles

A Prospective Study on Incidence, Risk Factors and Long-Term Outcome of Osteonecrosis in 694 Patients with Pediatric Acute Lymphoblastic Leukemia,

Mariël L. te Winkel, MD, Rob Pieters, MD, PhD, Wim C.J. Hop, PhD, Hester A. de Groot-Kruseman, PhD, Maarten H. Lequin, MD, PhD, Inge M. van der Sluis, MD, PhD, Jos P.M. Bökkerink, MD, PhD, Jan A. Leeuw, MD, Marrie C. A. Bruin, MD, PhD, R. Maarten Egeler, MD, PhD, Anjo J.P. Veerman, MD, PhD, Marry M. van den Heuvel-Eibrink, MD, PhD

Blood (2011) 118 (21): 3578.

https://doi.org/10.1182/blood.V118.21.3578.3578

Published: 2011

Journal Articles

Reduction in Incidence of Severe Infections by Transplantation of High Doses of Haploidentical T Cells Selectively Depleted of Alloreactive Units

Denis-Claude Roy, MD, Mireille Guerin, MSc, Radia Sidi Boumedine, MSc, Silvy Lachance, MD, Sandra Cohen, MD, Guy Sauvageau, MD, PhD, Thomas Kiss, MD, Lambert Busque, MD, Jean Morin, Marie-Claude Guertin, PhD, Andrea Velardi, MD, PhD, Katayoun Rezvani, MD, PhD, Stephan Mielke, MD, R. Maarten Egeler, MD, PhD, A. John Barrett, MD, Claude Perreault, MD, Jean Roy, MD

Blood (2011) 118 (21): 3020.

https://doi.org/10.1182/blood.V118.21.3020.3020

Published: 2011

Journal Articles

Novel Photodepletion Strategy to Preserve and Expand Tregs While Eliminating CD4+ Effector T Cells From Patients with Chronic Graft-Versus-Host Disease

Jean-Philippe Bastien, MSc, Gorazd Krosl, Ph.D, Cynthia Therien, BSc, MSc, Marissa Rashkovan, B.Sc, Christian Scotto, Ph.D, Sandra Cohen, MD, David S. Allan, MD, MSc, Donna E. Hogge, MD, PhD, R. Maarten Egeler, MD, Claude Perreault, MD, Denis-Claude Roy, MD

Blood (2010) 116 (21): 353.

https://doi.org/10.1182/blood.V116.21.353.353

Published: 2010

Journal Articles

Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome

Lynne Margaret Ball, MD, PhD, Maria E. Bernardo, MD, PhD, Jaap Jan Zwaginga, MD, PhD, Maarten van Tol, PhD, Angela Cometa, Helene Roelofs, PhD, Giovanna Giorgiani, Cornelia M Jol-van der Zijde, PhD, Maria Antonietta Avanzini, MD, Katarina Le Blanc, MD, PhD, Alice Bertaina, Francesco Frassoni, MD, Willem E. Fibbe, MD, PhD, Olle Ringden, MD, R. Maarten Egeler, MD, PhD, Franco Locatelli, MD, Arjan Lankester, MD, PhD

Blood (2010) 116 (21): 2336.

https://doi.org/10.1182/blood.V116.21.2336.2336

Published: 2010

Journal Articles

Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.

Denis-Claude Roy, MD, Silvy Lachance, MD, Thomas Kiss, MD, Sandra Cohen, MD, Lambert Busque, MD, Douglas Fish, MD, Guy Sauvageau, MD, PhD, Maarten Egeler, MD, Jean Roy, MD

Blood (2009) 114 (22): 512.

https://doi.org/10.1182/blood.V114.22.512.512

Published: 2009

Journal Articles

Parents’ Commitment to Participation in Mesenchymal Stem Cell Donation and Research Demonstrates Extensive Altruism to Other Patients.

Anne-Marie Walraven, MSc, RN, Maria-Ester Bernardo, MD, Anneke Brand, MD, PhD, Helene Roelofs, PhD, Franco Locatelli, MD, PhD, R. Maarten Egeler, MD, PhD, Willem E. Fibbe, MD, PhD, Lynne M. Ball, MD

Blood (2007) 110 (11): 5078.

https://doi.org/10.1182/blood.V110.11.5078.5078

Published: 2007

Journal Articles

Co-Transplantation of HLA-Haploidentical, Bone Marrow Derived Mesenchymal Stem Cells Prevents Graft Failure and Improves Hematological Recovery in T-Cell Depleted Haploidentical Stem Cell Transplantation.

Lynne M. Ball, MD, Maria-Ester Bernardo, MD, Helene Roelofs, PhD, Arjan Lankester, MD, PhD, Angela Cometa, MD, R. Maarten Egeler, MD, PhD, Angela Cometa, MD, Giovanna Giorgiani, MD, Franco Locatelli, MD, PhD, Willem E. Fibbe, MD, PhD

Blood (2007) 110 (11): 3073.

https://doi.org/10.1182/blood.V110.11.3073.3073

Published: 2007

Journal Articles

Co-Transplantation of Haploidentical Bone Marrow Derived Mesenchymal Stem Cells Overcomes Graft Dysfunction and Improves Hematological and Lymphocyte Recovery in Haploidentical Stem Cell Transplantation.

Lynne Margaret van Velzen-Ball, MD, Marie Ester Bernado, MD PhD, Franco Locatelli, MD PhD, Helene Roelofs, PhD, Arjan Lankester, MD PhD, R. Maarten Egeler, MD PhD, Willem E. Fibbe, MD PhD

Blood (2006) 108 (11): 3118.

https://doi.org/10.1182/blood.V108.11.3118.3118

Published: 2006

Journal Articles

Transplantation of Haplo-Identical Bone Marrow-Derived Mesenchymal Stem Cells Together with Hematopoietic Stem Cells To Promote Engraftment in Children. A Phase I/II Multicenter Study.

Lynne Margaret van Velzen-Ball, MD, PhD, Katarina Le Blanc, MD, PhD, Arjen C. Lankester, MD, PhD, Helene Roelofs, PhD, Maarten Egeler, MD, PhD, Francesco Frassoni, MD, PhD, Olle Ringdén, MD, PhD, Willem E. Fibbe, MD, PhD

Blood (2005) 106 (11): 2911.

https://doi.org/10.1182/blood.V106.11.2911.2911

Published: 2005

Journal Articles

A Human Anti-CD1a Monoclonal Antibody for Targeted Immunotherapy in Langerhans Cell Histiocytosis and Hematologic Malignancies.

Gitanjali Bechan, MD, David W. Lee, MS, R. Maarten Egeler, MD, PhD, Robert J. Arceci, MD, PhD

Blood (2005) 106 (11): 4815.

https://doi.org/10.1182/blood.V106.11.4815.4815

Published: 2005

NARROW

Bisphosphonate Therapy in Langerhans Cell Histiocytosis: An International Retrospective Descriptive Study

A Prospective Study on Incidence, Risk Factors and Long-Term Outcome of Osteonecrosis in 694 Patients with Pediatric Acute Lymphoblastic Leukemia,

Reduction in Incidence of Severe Infections by Transplantation of High Doses of Haploidentical T Cells Selectively Depleted of Alloreactive Units

Novel Photodepletion Strategy to Preserve and Expand Tregs While Eliminating CD4+ Effector T Cells From Patients with Chronic Graft-Versus-Host Disease

Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome

Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.

Parents’ Commitment to Participation in Mesenchymal Stem Cell Donation and Research Demonstrates Extensive Altruism to Other Patients.

Co-Transplantation of HLA-Haploidentical, Bone Marrow Derived Mesenchymal Stem Cells Prevents Graft Failure and Improves Hematological Recovery in T-Cell Depleted Haploidentical Stem Cell Transplantation.

Co-Transplantation of Haploidentical Bone Marrow Derived Mesenchymal Stem Cells Overcomes Graft Dysfunction and Improves Hematological and Lymphocyte Recovery in Haploidentical Stem Cell Transplantation.

Transplantation of Haplo-Identical Bone Marrow-Derived Mesenchymal Stem Cells Together with Hematopoietic Stem Cells To Promote Engraftment in Children. A Phase I/II Multicenter Study.

A Human Anti-CD1a Monoclonal Antibody for Targeted Immunotherapy in Langerhans Cell Histiocytosis and Hematologic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only